Wells Fargo
CELZ icon

Wells Fargo’s Creative Medical Technology CELZ Stock Holding History

Wells Fargo’s Portfolio CELZ Stock Details CELZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-5,000
Closed -$10.3K – 7325
2026
Q1 		$10.3K Buy
+5,000
New +$9.78K ﹤0.01% 5957
2024
Q2 		– Sell
-11
Closed -$57 – 6976
2024
Q1 		$57 Hold
11
– – ﹤0.01% 6789
2023
Q4 		$51 Sell
11
-19
-63% -$87 ﹤0.01% 6926
2023
Q3 		$147 Buy
30
+20
+200% +$102 ﹤0.01% 6659
2023
Q2 		$46 Hold
10
– – ﹤0.01% 7076
2023
Q1 		$49 Hold
10
– – ﹤0.01% 7113
2022
Q4 		$37 Buy
10
+1
+11% +$4 ﹤0.01% 7102
2022
Q3 		$0 Buy
9
+3
+50% +$20 ﹤0.01% 6712
2022
Q2 		$0 Buy
6
+2
+50% +$32 ﹤0.01% 6852
2022
Q1 		$0 Buy
+4
New +$89 ﹤0.01% 7108

Other funds holding CELZ

Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $36.8B AUM 42.13% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $1.68B AUM 373.57% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
GRP
Global Retirement Partners San Rafael, California $6.54B AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo's CELZ Position: Q2 2026 in Review

Wells Fargo sold out of Creative Medical Technology (CELZ) in Q2 2026, closing a stake of 5,000 shares — an estimated $10.3K sold.

Wells Fargo first reported a position in CELZ in Q1 2022 and held it in 10 quarters. The position peaked at $10.3K in Q1 2026. 15 funds tracked by Wall St. Rank hold CELZ as of Q2 2026.

  • Wells Fargo reported no remaining Creative Medical Technology position as of Q2 2026 after selling out during the quarter.
  • Wells Fargo sold 5,000 Creative Medical Technology shares in Q2 2026, an estimated $10.3K.
  • Wells Fargo first reported a position in Creative Medical Technology in Q1 2022 and held it in 10 quarters.
  • Wells Fargo's Creative Medical Technology position peaked at $10.3K in Q1 2026.
  • 15 funds tracked by Wall St. Rank held Creative Medical Technology as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.